vs
MARAVAI LIFESCIENCES HOLDINGS, INC.（MRVI）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
REGIS CORP的季度营收约是MARAVAI LIFESCIENCES HOLDINGS, INC.的1.1倍（$57.1M vs $49.9M），REGIS CORP净利率更高（0.8% vs -71.6%，领先72.4%），REGIS CORP同比增速更快（22.3% vs -11.8%），REGIS CORP自由现金流更多（$891.0K vs $-24.9M），过去两年REGIS CORP的营收复合增速更高（7.8% vs -11.9%）
Maravai生命科学控股是一家全球化生命科学企业，专注于开发供应关键试剂、诊断产品及技术解决方案，服务于生物制药研发、药物开发、临床诊断及细胞和基因疗法制造领域，客户覆盖全球相关科研、医疗和企业机构。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
MRVI vs RGS — 直观对比
营收规模更大
RGS
是对方的1.1倍
$49.9M
营收增速更快
RGS
高出34.1%
-11.8%
净利率更高
RGS
高出72.4%
-71.6%
自由现金流更多
RGS
多$25.8M
$-24.9M
两年增速更快
RGS
近两年复合增速
-11.9%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $49.9M | $57.1M |
| 净利润 | $-35.7M | $456.0K |
| 毛利率 | 25.8% | — |
| 营业利润率 | -117.9% | 10.8% |
| 净利率 | -71.6% | 0.8% |
| 营收同比 | -11.8% | 22.3% |
| 净利润同比 | -37.7% | -94.0% |
| 每股收益（稀释后） | $-0.24 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MRVIRGS
| Q4 25 | $49.9M | $57.1M | ||
| Q3 25 | $41.6M | $59.0M | ||
| Q2 25 | $47.4M | $60.4M | ||
| Q1 25 | $46.9M | $57.0M | ||
| Q4 24 | $56.6M | $46.7M | ||
| Q3 24 | $69.0M | $46.1M | ||
| Q2 24 | $69.4M | $49.4M | ||
| Q1 24 | $64.2M | $49.2M |
净利润MRVIRGS
| Q4 25 | $-35.7M | $456.0K | ||
| Q3 25 | $-25.6M | $1.4M | ||
| Q2 25 | $-39.6M | $116.5M | ||
| Q1 25 | $-29.9M | $250.0K | ||
| Q4 24 | $-25.9M | $7.6M | ||
| Q3 24 | $-97.1M | $-853.0K | ||
| Q2 24 | $-9.8M | $91.2M | ||
| Q1 24 | $-12.1M | $-2.3M |
毛利率MRVIRGS
| Q4 25 | 25.8% | — | ||
| Q3 25 | 13.6% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | 16.5% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 46.7% | — | ||
| Q2 24 | 44.4% | — | ||
| Q1 24 | 40.3% | — |
营业利润率MRVIRGS
| Q4 25 | -117.9% | 10.8% | ||
| Q3 25 | -98.6% | 10.0% | ||
| Q2 25 | -139.8% | 12.1% | ||
| Q1 25 | -104.9% | 8.8% | ||
| Q4 24 | -66.7% | 11.8% | ||
| Q3 24 | -239.9% | 4.6% | ||
| Q2 24 | -19.4% | — | ||
| Q1 24 | -29.4% | 8.3% |
净利率MRVIRGS
| Q4 25 | -71.6% | 0.8% | ||
| Q3 25 | -61.4% | 2.3% | ||
| Q2 25 | -83.5% | 192.9% | ||
| Q1 25 | -63.9% | 0.4% | ||
| Q4 24 | -45.8% | 16.4% | ||
| Q3 24 | -140.6% | -1.9% | ||
| Q2 24 | -14.1% | 184.7% | ||
| Q1 24 | -18.8% | -4.7% |
每股收益（稀释后）MRVIRGS
| Q4 25 | $-0.24 | $0.16 | ||
| Q3 25 | $-0.18 | $0.49 | ||
| Q2 25 | $-0.27 | $43.67 | ||
| Q1 25 | $-0.21 | $0.08 | ||
| Q4 24 | $-0.21 | $2.71 | ||
| Q3 24 | $-0.68 | $-0.36 | ||
| Q2 24 | $-0.07 | $38.40 | ||
| Q1 24 | $-0.09 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $216.9M | $18.4M |
| 总债务越低越好 | $291.8M | $113.3M |
| 股东权益账面价值 | $212.4M | $188.7M |
| 总资产 | $770.6M | $588.3M |
| 负债/权益比越低杠杆越低 | 1.37× | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资MRVIRGS
| Q4 25 | $216.9M | $18.4M | ||
| Q3 25 | $243.6M | $16.6M | ||
| Q2 25 | $269.9M | $17.0M | ||
| Q1 25 | $285.1M | $13.3M | ||
| Q4 24 | $322.4M | $10.2M | ||
| Q3 24 | $578.2M | $6.3M | ||
| Q2 24 | $573.2M | $10.1M | ||
| Q1 24 | $561.7M | $5.9M |
总债务MRVIRGS
| Q4 25 | $291.8M | $113.3M | ||
| Q3 25 | $292.8M | $111.3M | ||
| Q2 25 | $293.9M | $110.8M | ||
| Q1 25 | $294.9M | $112.0M | ||
| Q4 24 | $295.9M | $111.5M | ||
| Q3 24 | $521.7M | $95.2M | ||
| Q2 24 | $522.5M | $99.5M | ||
| Q1 24 | $523.3M | $179.7M |
股东权益MRVIRGS
| Q4 25 | $212.4M | $188.7M | ||
| Q3 25 | $245.4M | $187.6M | ||
| Q2 25 | $265.9M | $185.6M | ||
| Q1 25 | $300.6M | $68.6M | ||
| Q4 24 | $325.3M | $66.7M | ||
| Q3 24 | $344.9M | $56.4M | ||
| Q2 24 | $434.7M | $56.8M | ||
| Q1 24 | $410.7M | $-35.8M |
总资产MRVIRGS
| Q4 25 | $770.6M | $588.3M | ||
| Q3 25 | $849.2M | $592.1M | ||
| Q2 25 | $897.0M | $599.0M | ||
| Q1 25 | $959.8M | $511.2M | ||
| Q4 24 | $1.0B | $530.1M | ||
| Q3 24 | $1.3B | $508.9M | ||
| Q2 24 | $1.4B | $530.5M | ||
| Q1 24 | $1.4B | $543.7M |
负债/权益比MRVIRGS
| Q4 25 | 1.37× | 0.60× | ||
| Q3 25 | 1.19× | 0.59× | ||
| Q2 25 | 1.11× | 0.60× | ||
| Q1 25 | 0.98× | 1.63× | ||
| Q4 24 | 0.91× | 1.67× | ||
| Q3 24 | 1.51× | 1.69× | ||
| Q2 24 | 1.20× | 1.75× | ||
| Q1 24 | 1.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.8M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $-24.9M | $891.0K |
| 自由现金流率自由现金流/营收 | -49.9% | 1.6% |
| 资本支出强度资本支出/营收 | 4.2% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 3.65× |
| 过去12个月自由现金流最近4个季度 | $-70.7M | $14.9M |
8季度趋势，按日历期对齐
经营现金流MRVIRGS
| Q4 25 | $-22.8M | $1.7M | ||
| Q3 25 | $-15.2M | $2.3M | ||
| Q2 25 | $-10.3M | $6.8M | ||
| Q1 25 | $-9.4M | $6.2M | ||
| Q4 24 | $-14.6M | $2.1M | ||
| Q3 24 | $13.1M | $-1.3M | ||
| Q2 24 | $17.4M | $5.1M | ||
| Q1 24 | $-8.5M | $-277.0K |
自由现金流MRVIRGS
| Q4 25 | $-24.9M | $891.0K | ||
| Q3 25 | $-18.1M | $1.9M | ||
| Q2 25 | $-13.1M | $6.2M | ||
| Q1 25 | $-14.6M | $5.9M | ||
| Q4 24 | $-20.5M | $1.7M | ||
| Q3 24 | $4.5M | $-1.4M | ||
| Q2 24 | $7.9M | $5.1M | ||
| Q1 24 | $-14.1M | $-326.0K |
自由现金流率MRVIRGS
| Q4 25 | -49.9% | 1.6% | ||
| Q3 25 | -43.4% | 3.2% | ||
| Q2 25 | -27.7% | 10.3% | ||
| Q1 25 | -31.2% | 10.3% | ||
| Q4 24 | -36.2% | 3.6% | ||
| Q3 24 | 6.6% | -3.0% | ||
| Q2 24 | 11.4% | 10.3% | ||
| Q1 24 | -22.0% | -0.7% |
资本支出强度MRVIRGS
| Q4 25 | 4.2% | 1.4% | ||
| Q3 25 | 7.0% | 0.7% | ||
| Q2 25 | 6.1% | 0.9% | ||
| Q1 25 | 11.2% | 0.6% | ||
| Q4 24 | 10.3% | 0.9% | ||
| Q3 24 | 12.4% | 0.0% | ||
| Q2 24 | 13.8% | 0.0% | ||
| Q1 24 | 8.8% | 0.1% |
现金转化率MRVIRGS
| Q4 25 | — | 3.65× | ||
| Q3 25 | — | 1.68× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | — | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MRVI
| Cygnus Segment | $27.2M | 54% |
| Other | $18.4M | 37% |
| Shipping And Handling | $4.3M | 9% |
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
